Firefly Aerospace Is the Space Stock Nobody Is Talking About

Firefly Aerospace reported record Q2 revenue of $117.7 million, up 659% year over year, and guided for $420 million-$450 million of 2026 revenue. The company now has six contracted lunar missions, including a $144 million NASA award and a $75 million Elytra subcontract, while subsidiary SciTec won a $94 million Space Force contract. Growth prospects are supported by expanded Texas production capacity and defense-space opportunities, though Firefly remained loss-making with a $92.3 million Q2 net loss and faces substantial capital requirements.

Analysis

FLY’s investment case is transitioning from a single-asset launch valuation toward a portfolio-of-programs valuation, but the market should not capitalize contracted awards at face value. The key determinant over the next 1-3 quarters is conversion of backlog into milestone revenue and, more importantly, gross-margin progression as manufacturing capacity ramps. A rising revenue base with persistent negative operating leverage would force dilution and cap any rerating; credible evidence of positive contribution margin on lunar and orbital-service programs would justify a materially higher revenue multiple.

The less obvious beneficiary is NOC: its exposure offers participation in heavier-lift and national-security space demand without FLY’s execution, launch-failure, and financing risk. RKLB is the cleaner public comparable, but also a likely relative winner if investors conclude that vertical integration, flight cadence, and a larger balance sheet matter more than early lunar-mission credentials. Conversely, FLY’s pursuit of defense and in-space logistics could pressure smaller pure-play satellite servicing and launch vendors whose differentiation rests on addressable-market narratives rather than funded programs.

Near term, expect retail-driven volatility around contract announcements, launches, and quarterly backlog disclosures rather than a durable fundamental repricing. Over 6-18 months, the central risk is working-capital consumption: fixed-price government contracts can generate reported revenue while absorbing cash through schedule delays, testing failures, and customer acceptance gates. The bullish thesis is falsified by a material cut to forward revenue expectations, backlog conversion below plan, gross margin failing to improve with scale, or a capital raise before operating cash burn visibly narrows.

Consensus appears to be treating platform breadth as diversification; it may instead be correlated engineering and capital intensity. Multiple programs share constrained labor, test infrastructure, supplier capacity, and management attention, so one execution slip can propagate across launch, lunar, and orbital-service timelines. The stock is investable only after establishing whether its enterprise-value-to-forward-sales premium versus RKLB is supported by superior backlog quality, cash runway, and unit economics.

Key Decisions for Investors

• Do not initiate an outright FLY core long before the next earnings release; require disclosure of funded backlog, cash runway, quarterly operating cash burn, and gross-margin trajectory. A position is justified only if revenue conversion is accompanied by sequential margin improvement rather than higher losses.
• Preferred relative-value expression for the next 3-6 months: long RKLB / short FLY in equal dollar amounts if FLY trades at a material premium to RKLB on forward EV/sales without demonstrably superior funded backlog conversion. Target 15-25% relative return; exit if FLY reports positive contribution-margin inflection and cash burn narrows materially.
• Accumulate NOC on weakness as a lower-volatility defense-space proxy over 6-18 months. The risk/reward is less dependent on any single launch or lunar mission, while successful program scaling can create incremental partner and supply-chain upside; reassess if major-program funding is deferred in the federal budget cycle.
• Set event alerts for FLY launch outcomes, customer acceptance milestones, and any equity/debt financing. A successful sequence can drive a sharp momentum squeeze over days, while a launch anomaly or dilutive raise would likely overwhelm otherwise positive contract news.